Use of Immunosuppressants/Immunomodulators in Autoimmune/Inflammatory Dermatologic Diseases during COVID-19 Pandemic-General Recommendation Based on Available Evidence.
作者信息
De Dipankar, Pandhi Deepika
机构信息
Department of Dermatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Department of Dermatology and STD, University College of Medical Sciences and GTB Hospital, Delhi, India E-mail:
出版信息
Indian Dermatol Online J. 2020 Jul 13;11(4):526-533. doi: 10.4103/idoj.IDOJ_414_20. eCollection 2020 Jul-Aug.
Abstract
摘要
相似文献
1
Use of Immunosuppressants/Immunomodulators in Autoimmune/Inflammatory Dermatologic Diseases during COVID-19 Pandemic-General Recommendation Based on Available Evidence.2019冠状病毒病大流行期间自身免疫性/炎性皮肤病中免疫抑制剂/免疫调节剂的使用——基于现有证据的一般建议
Indian Dermatol Online J. 2020 Jul 13;11(4):526-533. doi: 10.4103/idoj.IDOJ_414_20. eCollection 2020 Jul-Aug.
2
Nosocomial Infections in COVID-19 Patients Treated with Immunomodulators: A Narrative Review.接受免疫调节剂治疗的COVID-19患者的医院感染：一项叙述性综述。
Front Biosci (Schol Ed). 2022 Sep 26;14(4):26. doi: 10.31083/j.fbs1404026.
3
Evidence-based best practice advice for patients treated with systemic immunosuppressants in relation to COVID-19.针对 COVID-19 接受全身免疫抑制剂治疗的患者的循证最佳实践建议。
Clin Dermatol. 2020 Nov-Dec;38(6):775-780. doi: 10.1016/j.clindermatol.2020.05.003. Epub 2020 May 14.
4
Considerations on Immunization and Immunosuppression of Patients With Autoimmune Blistering Diseases During COVID-19 Pandemic in Brazil: Case Report.巴西新冠疫情期间自身免疫性水疱病患者免疫接种与免疫抑制的考量：病例报告
Front Med (Lausanne). 2022 Apr 12;8:811562. doi: 10.3389/fmed.2021.811562. eCollection 2021.
5
Plant Derived Immunomodulators; A Critical Review.植物源免疫调节剂；批判性综述
Adv Pharm Bull. 2022 Aug;12(4):712-729. doi: 10.34172/apb.2022.074. Epub 2021 Oct 2.
6
Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS-CoV-2 (COVID-19) pandemic emergency: A quick review for a quick consultation.在 SARS-CoV-2（COVID-19）大流行期间治疗皮肤科疾病的全身性免疫生物学、免疫抑制剂和肿瘤药物：快速咨询的快速回顾。
Dermatol Ther. 2020 Sep;33(5):e13537. doi: 10.1111/dth.13537. Epub 2020 Jun 24.
7
Malignancy risk of non-biologic immunosuppressive therapies: A review of the literature with evidence-based treatment recommendations.非生物免疫抑制疗法的恶性肿瘤风险：文献综述及基于证据的治疗建议。
Exp Dermatol. 2022 Nov;31(11):1656-1664. doi: 10.1111/exd.14647. Epub 2022 Jul 27.
8
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey.特发性炎性肌病、其他系统性自身免疫和炎症性疾病以及健康对照者中的 COVID-19 严重程度和疫苗突破性感染：来自 COVID-19 自身免疫疾病疫苗接种（COVAD）调查的一项多中心横断面研究。
Rheumatol Int. 2023 Jan;43(1):47-58. doi: 10.1007/s00296-022-05229-7. Epub 2022 Oct 22.
9
[Benefit of therapeutic drug monitoring of immunosuppressants and immunomodulators in the management of autoimmune diseases].[免疫抑制剂和免疫调节剂治疗药物监测在自身免疫性疾病管理中的益处]
Rev Med Interne. 2022 Jul;43(7):412-418. doi: 10.1016/j.revmed.2022.03.343. Epub 2022 May 25.
10
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.使用免疫抑制剂的免疫介导炎症性疾病的接种疫苗患者中出现的德尔塔（B.1.617.2）变异株导致的严重急性呼吸综合征冠状病毒2突破性感染：两项前瞻性队列研究的子研究
Lancet Rheumatol. 2022 Jun;4(6):e417-e429. doi: 10.1016/S2665-9913(22)00102-3. Epub 2022 Apr 29.
引用本文的文献
1
Live vaccinations in dermatology for immunosuppressed patients: a narrative review.皮肤科免疫抑制患者的活疫苗接种：叙述性综述。
Arch Dermatol Res. 2024 Mar 2;316(3):96. doi: 10.1007/s00403-024-02827-2.
2
Management of Vitiligo Amidst the COVID-19 Pandemic: A Survey and Resulting Consensus.2019冠状病毒病大流行期间白癜风的管理：一项调查及形成的共识
Indian J Dermatol. 2021 Sep-Oct;66(5):479-483. doi: 10.4103/ijd.ijd_859_20.
3
Evaluation of the Knowledge, Attitude and Practice of Patients on Immunosuppressive Drugs Towards COVID-19 Attending Dermatology Department- A Multicentric Cross-Section Study.皮肤科就诊的 COVID-19 患者对免疫抑制药物的知识、态度和实践评估——一项多中心横断面研究
Indian J Dermatol. 2021 Jul-Aug;66(4):446. doi: 10.4103/ijd.IJD_92_21.
4
Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS-CoV-2.血浆置换：治疗 COVID-19 感染大疱性类天疱疮患者的可行选择
Int J Dermatol. 2022 Feb;61(2):252-256. doi: 10.1111/ijd.15892. Epub 2021 Sep 14.
5
Psoriasis Management During the COVID-19 Pandemic: Recommendations by SIG Psoriasis (IADVL Academy).2019冠状病毒病大流行期间的银屑病管理：银屑病特别兴趣小组（印度皮肤科、性病与麻风病学协会学会）的建议
Indian Dermatol Online J. 2021 Jan 16;12(1):58-65. doi: 10.4103/idoj.IDOJ_685_20. eCollection 2021 Jan-Feb.
本文引用的文献
1
Management of Leprosy in the Context of COVID-19 Pandemic: Recommendations by SIG Leprosy (IADVL Academy).2019冠状病毒病大流行背景下的麻风病管理：印度皮肤病学、性病学与麻风病学学会（IADVL学会）的建议
Indian Dermatol Online J. 2020 May 10;11(3):345-348. doi: 10.4103/idoj.IDOJ_234_20. eCollection 2020 May-Jun.
2
Covid-19 infection in psoriasis patients treated with cyclosporin.接受环孢素治疗的银屑病患者感染新冠病毒19
Dermatol Ther. 2020 Jul;33(4):e13739. doi: 10.1111/dth.13739. Epub 2020 Jun 24.
3
Use of systemic therapies for psoriasis in the COVID-19 era.COVID-19 时代的银屑病全身治疗。
J Dermatolog Treat. 2022 Mar;33(2):622-625. doi: 10.1080/09546634.2020.1775774. Epub 2021 Jan 28.
4
Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.儿童 COVID-19 感染相关的多形性红斑和川崎病。
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e539-e541. doi: 10.1111/jdv.16666. Epub 2020 Jul 6.
5
Erythema multiforme-like lesions in children and COVID-19.儿童多形红斑样皮损与新型冠状病毒肺炎
Pediatr Dermatol. 2020 May;37(3):442-446. doi: 10.1111/pde.14246.
6
The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic.接受白细胞介素17通路抑制生物制剂治疗的银屑病患者发生呼吸道感染和症状的风险：对COVID-19大流行期间决策相关关键试验的荟萃估计。
J Am Acad Dermatol. 2020 Aug;83(2):677-679. doi: 10.1016/j.jaad.2020.05.035. Epub 2020 May 19.
7
Acute generalized exanthematous pustulosis with erythema multiforme-like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID-19).一名患有2019冠状病毒病（COVID-19）的女性因服用羟氯喹引发急性泛发性脓疱性皮病伴多形红斑样皮损
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e457-e459. doi: 10.1111/jdv.16613. Epub 2020 Jul 3.
8
Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings.新型冠状病毒肺炎感染患者的多形红斑样皮疹：临床和组织学表现
Clin Exp Dermatol. 2020 Oct;45(7):892-895. doi: 10.1111/ced.14281. Epub 2020 Jun 25.
9
Cyclosporine therapy during the COVID-19 pandemic.新冠疫情期间的环孢素治疗。
J Am Acad Dermatol. 2020 Aug;83(2):e151-e152. doi: 10.1016/j.jaad.2020.04.153. Epub 2020 May 4.
10
Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus.2019年冠状病毒病：对系统性红斑狼疮患者护理与管理的启示
Eur J Rheumatol. 2020 Aug;7(Suppl 2):S117-S120. doi: 10.5152/eurjrheum.2020.20055. Epub 2020 Apr 8.
Zotero 插件